Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

The average age of men who get diagnosed is 67.

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Clinical node involvement on preoperative PSMA-PET predicts radiographic recurrence for pN1 prostate cancer patients following RP/PLND.

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...

SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) was a Phase II multi-centre, single arm, non-randomised, open-label copper-64 labelled SAR-Bombesin PET imaging trial of ...

While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...

Former president Joe Biden was diagnosed with an aggressive form of prostate cancer, his spokesperson announced on Sunday. Biden, 82, is currently reviewing his treatment options with his family and ...